TrialPloS one2017

The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial.

B A S Jaeger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.